ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75 | -90.1% | 569,566 | -61.6% | 0.01% | -92.1% |
| Q2 2023 | $756 | +8.8% | 1,481,793 | +34.3% | 0.08% | +10.1% |
| Q1 2023 | $695 | +11.9% | 1,102,975 | +15.2% | 0.07% | -10.4% |
| Q4 2022 | $621 | -99.9% | 957,348 | +57.4% | 0.08% | -44.6% |
| Q3 2022 | $1,046,000 | -10.2% | 608,037 | -35.3% | 0.14% | -20.6% |
| Q2 2022 | $1,165,000 | +666.4% | 939,214 | +304.1% | 0.18% | +775.0% |
| Q1 2022 | $152,000 | +126.9% | 232,438 | +2088.7% | 0.02% | +400.0% |
| Q1 2017 | $67,000 | -81.1% | 10,620 | -77.8% | 0.00% | -82.6% |
| Q1 2016 | $355,000 | +143.2% | 47,819 | +171.7% | 0.02% | +228.6% |
| Q4 2015 | $146,000 | +46.0% | 17,600 | +58.0% | 0.01% | +40.0% |
| Q3 2015 | $100,000 | -57.1% | 11,142 | -42.6% | 0.01% | -44.4% |
| Q2 2015 | $233,000 | – | 19,421 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |